Preferred Label : Rezafungin;

UNII : G013B5478J;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/rezzayo-rezafungine
2024
false
false
false
France
French
Rezafungin
drug information

---
https://www.ema.europa.eu/en/medicines/human/EPAR/rezzayo
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Rezafungin
Rezafungin
rezafungin acetate
orphan drug production
drug approval
europe
antifungal agents
antifungal agents
adult
candidiasis, invasive
infusions, intravenous
risk management
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
Rezafungin Acetate
Rezafungin Acetate
aged
beta-(1,3)-D-glucan synthase
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3520341/fr/rezzayo-rezafungine-antifongique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antifungal agents
rezafungin acetate
candidiasis, invasive
infusions, intravenous
orphan drug production
adult
evaluation of the transparency committee
Rezafungin Acetate
Rezafungin

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-07-04-2023-sur-le-medicament-rezafungine-mundipharma-200-mg-poudre-pour-solution-a-diluer-pour-perfusion-dans-le-cadre-dune-demande-daap
2023
false
false
false
France
French
drug information
Rezafungin
rezafungin acetate
antifungal agents
infusions, intravenous
adult
candidemia
candidiasis, invasive

---
https://www.has-sante.fr/jcms/p_3434508/fr/rezafungine-mundipharma-rezafungine-antifongique
2023
France
evaluation of the transparency committee
Rezafungin
antifungal agents
Rezafungin
Antifungal agents

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.